Phenotype of atopic dermatitis subjects with a history of eczema herpeticum. - Test2 - elhamkhani - TriplyDB

Phenotype of atopic dermatitis subjects with a history of eczema herpeticum.

Phenotype of atopic dermatitis subjects with a history of eczema herpeticum.

http://www.wikidata.org/entity/Q34663953

about

DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice Diagnosis of Atopic Dermatitis: Mimics, Overlaps, and Complications Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches The importance of TSLP in allergic disease and its role as a potential therapeutic target Genetic and epigenetic studies of atopic dermatitis Vaccinia virus-specific molecular signature in atopic dermatitis skin.Recent insights into atopic dermatitis and implications for management of infectious complications.Mast cells in atopic dermatitis Atopic dermatitis keratinocytes exhibit normal T(H)17 cytokine responses.An update on the genetics of atopic dermatitis: scratching the surface in 2009.Filaggrin-stratified transcriptomic analysis of pediatric skin identifies mechanistic pathways in patients with atopic dermatitis.The infectious aspects of atopic dermatitis.Vitamin D in atopic dermatitis, asthma and allergic diseases.Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum.History of eczema herpeticum is associated with the inability to induce human β-defensin (HBD)-2, HBD-3 and cathelicidin in the skin of patients with atopic dermatitis.Identification of novel gene signatures in patients with atopic dermatitis complicated by eczema herpeticum.Staphylococcal and streptococcal superantigen exotoxins Immune response to varicella vaccine in children with atopic dermatitis compared with nonatopic controls.Tight junction defects in patients with atopic dermatitis.Comparative proteomic profiling of patients with atopic dermatitis based on history of eczema herpeticum infection and Staphylococcus aureus colonization.Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-γ response.Atopic dermo-respiratory syndrome is a correlate of eczema herpeticum.Atopic dermatitis: a disease of altered skin barrier and immune dysregulation.Reductions in claudin-1 may enhance susceptibility to herpes simplex virus 1 infections in atopic dermatitis Critical role for mast cell Stat5 activity in skin inflammation Inhibition of transcription factor specificity protein 1 alters the gene expression profile of keratinocytes leading to upregulation of kallikrein-related peptidases and thymic stromal lymphopoietin.The signal transducer and activator of transcription 6 gene (STAT6) increases the propensity of patients with atopic dermatitis toward disseminated viral skin infections.Mannan-binding lectin levels and activity are not altered in atopic dermatitis patients with a history of eczema herpeticum Thymic stromal lymphopoietin variation, filaggrin loss of function, and the persistence of atopic dermatitis Epidermal barrier in atopic dermatitis.Genetic variants in interferon regulatory factor 2 (IRF2) are associated with atopic dermatitis and eczema herpeticum.Susceptibility to vaccinia virus infection and spread in mice is determined by age at infection, allergen sensitization and mast cell status Targeted deep sequencing identifies rare loss-of-function variants in IFNGR1 for risk of atopic dermatitis complicated by eczema herpeticum.Staphylococcus aureus α-toxin modulates skin host response to viral infection.Comorbidity in Atopic Dermatitis.Specificity protein 1 is pivotal in the skin's antiviral response.Why is eczema herpeticum unexpectedly rare?IL-25 enhances HSV-1 replication by inhibiting filaggrin expression, and acts synergistically with Th2 cytokines to enhance HSV-1 replication.Relationship Between the Presence of Eczema Herpeticum and the Significance of Clinical and Laboratory Tests in Korean Children With Atopic Dermatitis.Clinical Diversity of Atopic Dermatitis: A Review of 5,000 Patients at a Single Institute.

P2860

Q24293628-49C7FAE5-88DF-49E1-85EC-55C1DDE9FCA6 Q26799526-8C2E334F-14CC-48F7-9F87-E0185F846C2A Q26852335-79883628-2735-4CE9-97A6-0BBB57C1CE8F Q27014178-3A85DE58-1FDB-45C7-B75A-EFC324E64F13 Q28073454-7F392BE8-0ADC-4F12-8D17-A92EB4180946 Q33621491-07E7F1E8-F408-494B-96AC-532799C6B349 Q33621496-83CF7C5C-1C48-46B6-9F69-CF9967C30FE6 Q33731849-8C1848A9-D9C7-46E1-99D9-5D311E93E201 Q33762291-24B7EBD1-5856-4095-95EF-40CB6E7B9EDC Q33868032-22D80147-7D0E-4336-B8DD-3D6BE41F73D9 Q33877517-B8E3D042-609F-4BE7-B909-D826FD93ED6C Q34032522-03245862-1881-4F3F-981E-7FB7C347EEEF Q34037783-7981EA89-4479-4033-8329-9B0182BA5896 Q34078819-02BD4A5C-5BFC-4F6F-ABAB-054751A13556 Q34253233-6A057813-EBA3-433A-8839-E17093526730 Q34294746-1FC0E45F-B969-47CC-BB18-E695F3C2066C Q34355243-12C9F9AD-3378-44D8-BF23-7B57ADADDDD7 Q34388371-8DCE8ABD-1368-4DB7-AFFF-B577338AC38B Q34629278-82376735-EFD1-48BD-9658-0162D690217B Q34686545-E1789F12-4CA8-4A7F-BB17-49353765211D Q34781786-C9E90C28-FCC9-436A-BB26-1A7B3838A1DA Q34860988-5FB211AF-6322-40C0-97F5-4F7010AAD2D9 Q35065037-A6241C36-C0D3-4118-BEFF-11D23392585E Q35085856-61A575DD-F0C9-446B-9F4E-D42A0F3584D7 Q35087816-A5418AB8-EB1F-44B9-AAB1-F266B04B7505 Q35349913-EAD00398-333F-4232-9829-A01FC2A98B65 Q35490893-1B63B670-E2CA-4471-B594-EBD7C3644AC7 Q35550639-8DA4AE1B-66F4-49A7-AAC5-2B575085960E Q35553105-4118868A-A95E-43AF-8F3A-587116CABC78 Q35622183-512E5D12-AAD3-4488-B117-5673920EE3D3 Q35754287-742782A8-92C5-43F9-9E03-85F952213F7A Q35795457-F0B5F338-D8E8-450E-AB71-3A9C16BA7E65 Q36372787-1B755A3E-2DE8-4879-8465-36AC510F63A6 Q36676808-DA107E69-6DDA-4567-B15E-11F280E7B37A Q36899783-4A493267-4233-4014-B50D-3336A54C8A01 Q37073740-10F19948-6D29-45DD-8C7F-41B14E25E564 Q37173732-BC978A2B-4485-4ABD-BD07-4D0D17C3F9CE Q37203388-3C3EFF69-2978-493D-A66C-F203BAE02168 Q37302226-D4BC632D-CFFE-4BA4-9078-40D72FE0C733 Q37606278-9DACA379-AF11-483A-AD49-DA509971BF63

P2860

Phenotype of atopic dermatitis subjects with a history of eczema herpeticum.

http://www.wikidata.org/entity/Q34663953

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Phenotype of atopic dermatitis subjects with a history of eczema herpeticum.

@ast

Phenotype of atopic dermatitis subjects with a history of eczema herpeticum.

@en

Phenotype of atopic dermatitis subjects with a history of eczema herpeticum.

@nl

type

label

Phenotype of atopic dermatitis subjects with a history of eczema herpeticum.

@ast

Phenotype of atopic dermatitis subjects with a history of eczema herpeticum.

@en

Phenotype of atopic dermatitis subjects with a history of eczema herpeticum.

@nl

prefLabel

Phenotype of atopic dermatitis subjects with a history of eczema herpeticum.

@ast

Phenotype of atopic dermatitis subjects with a history of eczema herpeticum.

@en

Phenotype of atopic dermatitis subjects with a history of eczema herpeticum.

@nl

P1433

Q34663953-CC4090A6-A479-40BF-B59A-62526BED1D58

P1476

Q34663953-94BFB268-359E-48A6-ACBD-E3F91D069DF5

P2093

Q34663953-21397B06-013F-4628-A775-529B1576D57C

Q34663953-2D4560A5-A939-4F93-BC0C-83EDA1303C42

Q34663953-2E487BA5-F56E-44D4-A09F-72A67DF2949C

Q34663953-390DA818-899B-4F8A-9AAB-5E72D3C761AD

Q34663953-3F106F05-343A-49C4-B037-F80137823B82

Q34663953-59FB4EA6-2E69-44E7-8E7E-3915EA1DA4BF

Q34663953-8BF9CF2B-DA76-4F51-B719-82B2E623ADC0

Q34663953-A4014910-CF32-4992-AB02-889B9A9DE2F6

Q34663953-AD97763E-40E6-4304-B58F-DB2036AD8FF5

Q34663953-BFD6D831-7ABA-47C8-AFA3-F6A6D2312053

P2860

Q34663953-027F89FD-3EDB-4BB4-89ED-30AE0B058A06

Q34663953-0BD2D6CC-C085-4D22-B053-C4D9E2FDB072

Q34663953-189ECCA4-E5CC-4941-836F-83C328F94183

Q34663953-191F873B-45C6-438A-A396-FE390D01925A

Q34663953-1B2B4413-6138-4F48-99A3-352494473173

Q34663953-238703C2-2AA5-4D1F-B7A9-C6F38BBD8304

Q34663953-367D15D3-FB5E-4C51-BC9B-B0F4BD4F643E

Q34663953-3BFACA8E-74A1-46A1-A03E-AC8883981E7C

Q34663953-3D0762BF-E20D-47B0-8D8F-D4C1300403B9

Q34663953-4F1600E9-2D1A-4BEE-A8D8-3ED50755F5A8

P304

Q34663953-F8CB6878-F666-4D06-B516-EF2D73EE3674

P31

Q34663953-E68F86B3-D3B7-4B3B-960E-4EE4A90ABD7A

P356

Q34663953-6C3669FC-1AC4-401F-A19A-1D47E31975FD

P407

Q34663953-24B8AAA9-D98C-4152-A3D6-2EFC733781F3

P433

Q34663953-3F0399F8-F551-4E4B-8E01-1CF5813B5F8A

P478

Q34663953-AB350B7A-FE4A-4FFD-B52F-BF9D8F7DC3DA

P50

Q34663953-0F3DD544-11BD-4AA0-B7CD-E29E5EE82FC0

Q34663953-B5B6C669-E18E-4971-B7E6-675A22146826

P577

Q34663953-D269084E-69EE-4CDC-8A8C-915115F48574

P5875

Q34663953-11009885-5BCC-4574-95B6-1438AB91B8EB

P698

Q34663953-97FC313B-CCB4-47E0-9C27-EFC4CC095810

P932

Q34663953-CEC5B222-E131-4FDE-8F71-D14A4FF259DA

P356

J.JACI.2009.05.020

P1433

The Journal of Allergy and Clinical Immunology

P1476

Phenotype of atopic dermatitis subjects with a history of eczema herpeticum

@en

P2093

Daniel Zaccaro

http://www.w3.org/2001/XMLSchema#string

Donald Y M Leung

http://www.w3.org/2001/XMLSchema#string

Henry Milgrom

http://www.w3.org/2001/XMLSchema#string

Jamie Reese

http://www.w3.org/2001/XMLSchema#string

Jon Hanifin

http://www.w3.org/2001/XMLSchema#string

Kathleen C Barnes

http://www.w3.org/2001/XMLSchema#string

Lisa A Beck

http://www.w3.org/2001/XMLSchema#string

Lynda C Schneider

http://www.w3.org/2001/XMLSchema#string

Mark Boguniewicz

http://www.w3.org/2001/XMLSchema#string

Susi Lieff

http://www.w3.org/2001/XMLSchema#string

P2860

Antimicrobial peptides and the skin immune defense system

Preferential expression of T(h)2-type chemokine and its receptor in atopic dermatitis

Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis

Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity.

Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis.

Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States.

Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity.

The evaluation and management of food allergy in atopic dermatitis.

Consensus conference on pediatric atopic dermatitis.

Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6

P304

260-9, 269.e1-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACI.2009.05.020

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26306132

http://www.w3.org/2001/XMLSchema#string

P698

19541356

http://www.w3.org/2001/XMLSchema#string

P932

3056058

http://www.w3.org/2001/XMLSchema#string